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Abstract
Background: We report on a 21-year-old patient with a giant symptomatic hydatid cyst of the interventricular
septum, to whom a staged management approach was employed. Induction medical therapy led to a reduction
in the size of the cyst, which was then completely removed via surgical excision.
Case presentation: A 21-year-old male Caucasian, with main complaints of fatigue and palpitations, was referred to
our Centre due to a cystic formation in his left ventricle. The workup consisted of transthoracic echocardiography and
cardiac magnetic resonance, which revealed a huge hydatid cyst in an active stage of disease, occupying the basal and
mid part of the interventricular septum. Due to the size of the lesion and lack of viable myocardium in the affected
area, the patient was declared inoperable and medical therapy was initiated. Serial echocardiography revealed a
significant reduction in the size of the lesion and degradation to transitional and inactive stage, after which successful
surgical excision of the cyst was performed. In the course of the medical treatment, the patient experienced sustained
ventricular tachycardia causing loss of consciousness, which did not reoccur after surgical excision.
Conclusion: Medical therapy can result in the degradation of a giant heart hydatid cyst, enabling surgical excision.
Heart hydatid cyst can lead to potentially lethal arrhythmia irrespective of its size and stage, which does not reoccur
after successful surgical excision.
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Background
Echinococcosis is a protozoal infection usually affecting
people living in rural, sheep-raising areas. Although it is
currently rare in developed Western countries, globalization,
increasing travel opportunities and migrations harbor the
potential to raise its prevalence. Infection most commonly
affects the liver and lungs (70 and 20% of cases, respect-
ively). Cardiac involvement is observed in less than 2% of
cases, with the primary infection of the heart being ex-
tremely rare (< 0.2%) [1]. It can be found in any part of the
myocardium, but it is most commonly located in the free
wall of the left ventricle (LV). Interventricular septal (IVS)
involvement is observed in 4% of cases [2]. Most patients
are asymptomatic. Dyspnea, palpitations and chest pain [3]
occur in a minority of patients. The preferred management
option remains complete surgical excision, due to the risk of
cyst rupture. The latter is associated with a high mortality
risk, secondary to acute pulmonary hypertension, peripheral
embolization and anaphylactic reactions [4]. The corner-
stones of medical therapy are albendazole and praziquantel.
A typical diagnostic algorithm includes echocardiography
and computed tomography or cardiac magnetic resonance
(CMR) [5]. Although ultrasound is a cornerstone of diag-
nosis, magnetic resonance with heavily T2-weihgted series
is preferable to computed tomography for extrahepatic
echinococcosis [6]. Either way, imaging is used to classify
lesions into six types, which define three stages of the
disease; active, transitional and inactive [7]. Management
options are affected by disease staging, as inactive cysts
have the lowest chance of rupture [8]. Most often, after
imaging, serology testing (Western blot and enzyme-linked
immunosorbent assay) is performed to confirm the diag-
nosis. Definitive confirmation is based on pathohistological
examination of intraoperative specimens.
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The aim of this case report is to present successful
staged management approach in the treatment of a giant
hydatid cyst, in which medical therapy led to cyst degrad-
ation, enabling surgical excision.
Case presentation
A 21-year-old male Caucasian was referred to our Center
due to a cystic formation in his LV. He is a student and
lives in a house with his parents, in a rural area of the
country, but they do not work in agriculture. He com-
plained about fatigue and weakness with exertion, as well
as palpitations and blurred vision. He was completely
asymptomatic up until 6 months prior to his current
presentation. His physical examination was unremarkable.
His high sensitive troponin T and N-terminal -pro-brain
natriuretic peptide were normal. His 24-h electrocardio-
gram was notable for non-sustained ventricular tachycar-
dia and biphasic T waves.
Transthoracic echocardiography (TTE) revealed a multi-
vesicular, septated cystic formation with a thin outer wall,
within the basal and mid part of the IVS. The largest
daughter cyst measured 6.5 × 6 cm and protruded into LV
cavity (Fig. 1a). All the other daughter cysts protruded into
the right ventricle (RV) (Fig. 1a). Mild inflow obstruction
of the RV was present. No connections between the
cysts and blood flow were observed on continuous-wave
Doppler and color-flow mapping. Further workup con-
sisted of CMR, which corroborated the TTE findings.
Total lesion size was 8.2 × 7.6 × 6 cm. Residual myocar-
dium was present only in the apical segments of the IVS,
while none was observed in the affected area (Fig. 1b).
Thoracic and abdominal imaging revealed multiple hep-
atic cysts. Serologic confirmation of echinoccocal infection
was performed with Western blot and enzyme-linked im-
munosorbent assay. Based on its imaging characteristics,
the cystic pathology was described as a type 2 active
lesion.
Technical challenges from a surgical perspective included
total removal of the cyst without disseminating its contents,
as well as a potentially complex reconstruction of the IVS.
Consequently, medical therapy with albendazole (dose:
15 mg/kg) was initiated. Bisoprolol and amiodarone
were administered due to ventricular arrhythmia. Over
the next 8 weeks, the patient was monitored closely and
serial TTE examinations revealed a great reduction in
total cyst size (Fig. 1c). Downsizing was observed in all
daughter cysts, with practically complete degeneration
of the largest daughter cyst. Furthermore, its content
Fig. 1 Giant hydatid cyst in the interventricular septum; (a) 2D transthoracic echocardiography, apical 4-chamber view and (b) cardiac magnetic
resonance, short axis view - showing largest daughter cyst protruding in the left ventricle cavity while smaller daughter cysts protrudes in the
right ventricle. c 2D transthoracic echocardiography, apical 4-chamber view and (d) cardiac magnetic resonance, short axis view – after 8 weeks
of albendazole therapy, showing degradation of daughter cysts with the consequent reduction of the total hydatid cyst size. (HC = hydatid cyst,
LA = left atrium, LV = left ventricle, RA = right atrium, RV = right ventricle)
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was denser and more compact, just as its outer wall
was thicker. These findings were confirmed on the
CMR – the size of the hydatid cyst was now 6.8 × 2.8 ×
5.1 cm and the outer layer was fibrotic (Fig. 1d). Based
on these findings the cyst was then classified as transi-
tional, borderline inactive. We found neither imaging
nor clinical evidence of cyst rupture. Nevertheless, full
body checkup was repeated and no signs of spreading
infection or embolism were observed. Praziquantel, in
the total dose of 50 mg/kg, divided into 3 doses per
day, during 14 days, was added to the therapy, after
which surgery was scheduled. During this period the
patient experienced an episode of sustained ventricular
tachycardia accompanied by loss of consciousness.
The surgical procedure consisted of several steps. After
the initiation of cardiopulmonary bypass and cardioplegic
arrest, a right atriotomy was performed and the pathology
could be seen through the tricuspid valve. A protrusion
within the IVS was clearly visible, and corresponded to
the imaging data. Initially, a purse string was placed in the
fibrous wall of the cyst. Then, controlled aspiration of its
fluid content was performed, which effectively reduced
the size of the cyst, as well as the tension within it. The
opening in the cyst was then enlarged in order to gain
access to the remainder of its contents (Fig. 2). The cyst
was filled with multiple smaller cysts suspended in a more
liquid substrate. All of these were removed, taking care
not to disseminate their contents (Fig. 3). Upon the
removal of the substrate, pericyst was packed with 10%
sodium chloride. Sponges impregnated with the solution
were left in place for 15min. The inner layer of the pericyst
was destroyed with a combination of mechanical abrasion
and chemical agents. The free edges of the pericyst were
then resected, and the integrity of the IVS checked. The
operation was completed in the standard fashion. Intraop-
erative transesophageal echocardiography was used to
confirm IVS integrity and tricuspid valve competence.
Pathological and microbiological analysis of the intraopera-
tively collected material confirmed the initial diagnosis.
The patient had an unremarkable postoperative course.
Postoperative TTE demonstrated normal size and func-
tion of both ventricles with an aneurysm of the basal IVS
but with no signs of an interventricular shunt (Fig. 4).
Medical therapy with albendazole was continued for three
additional cycles of 28 days each, with 14-day intervals
between 28-day cycles. Six weeks later, clinical and TTE
examination results were unchanged. The hepatic lesions
were addressed after the cardiac surgical procedure. At
6-month follow-up the patient remains well and free of
Fig. 2 Intraoperative view of the hydatid cyst through the tricuspid
valve. The arrow points to the surgically created orifice of the cyst.
(RA = right atrium)
Fig. 3 Multiple daughter cysts removed from the primary hydatid cyst
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disease recurrence or ventricular arrhythmia (Additional
file 1).
Discussion and conclusion
The case presented here stands out for several reasons.
The size and location of the cyst within the interventicular
septum provided a distinctive management challenge. Our
patient also had RV inflow obstruction compounded by
ventricular tachycardia. Hydatid cysts within the heart
have only rarely been found to exceed 5 cm in size.
Only one surgically treated giant IVS hydatid cyst has
been described so far, which resulted in death due to
RV failure [9].
We adopted a staged approach in the management of
this lesion. Presurgical medical management was also
employed in order to reduce the activity of the target
pathology and to reduce the likelihood of echinoccocus
dissemination. During the course of antimicrobial treat-
ment, we saw a progressive diminution in the size of the
cyst. A reduction in the size of a hydatid cyst is an excep-
tionally rare event, and one which, to the best of our
knowledge, has only been described once before [10]. We
opted to exploit this beneficial trend, as the original cyst
size with the accompanying distortion of cardiac struc-
tures would potentially have required a more complex
intracardiac surgical reconstruction. This staged approach
led to the successful management of our patient, who was
subjected to a technically far simpler operation than the
one originally believed to be necessary. While the inci-
dence of rupture of inactive hydatid cysts is low, their
potential to cause malignant ventricular arrhythmias is
unaffected by cyst activity. Surgical excision eliminates the
risk of recurrent ventricular arrhythmia [11–13].
Echinococcosis of the heart is a rare but potentially
lethal infection. Echocardiography and CMR are not only
useful in establishing the diagnosis, but also in defining
disease activity.
While only surgery is curative, presurgical medical
management can limit cyst growth, but, in rare cases, it
may also lead to regression in size. Individual timing of the
surgery provides the best chance for optimal outcomes.
Patients with echinoccocal cysts harbor the potential
for malignant arrhythmia development and inflow/out-
flow obstructions, warranting a high level of suspicion
as to these events.
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